Digital Health, Big Data, and What Pharma Learned from COVID-19

With 2020 in the rear view mirror and 2021 ahead, speakers discuss lessons learned by pharma during the pandemic and the role digital health, interoperability, and real world evidence will play in reshaping clinical trials and accelerating future drug development.

The successful development of the COVID-19 vaccine in less than a year and its ongoing distribution has created a rare transformative moment. Long linked to high drug prices, the pharmaceutical industry now has an opportunity to reintroduce itself to the marketplace as a powerful, positive force for innovation, health and patient well-being.

Join HIMSS for this wide-ranging discussion to learn what the digital ecosystem looked like for pharma before COVID and how it may change post-pandemic to accelerate product development and enhance patient centricity.

Key discussion points:

Lessons learned by pharma on accelerating innovation and time-to-market during the pandemic
How pharmaceutical companies can collaborate more effectively with healthcare providers
The role of real world evidence to demonstrate therapeutic value and efficacy
How AI can help analyze large amounts of data and move the needle on personalized care

Satasuk “Joy” Bhosai

Co-Director, Digital Health Solutions
Duke Clinical Research Institute

Amir Zur

Senior Director, Head of Products of Digital Health
Teva Pharmaceuticals

Amir Zur is a Sr. Director, Head of Products of Digital Health in Teva Pharmaceuticals.

Mr. Zur leads the digital portfolio and roadmap, definition, development life-cycle and quality to build Drug-Device Combination and Medical Device products in order to improve outcomes and treatments to patients.
Previously at Teva, he led the teams who built a novel innovative product from scratch and established digital foundations, processes and transformation in the company. The product was recently approved by the FDA as the first of its kind in respiratory and in the entire Health industry.

During his career Amir held vast leadership roles as an executive manager for more than 20 years in the digital industry both global large companies as Intel and Perion and as well as agile small and mid-companies.

Paddy Padmanabhan

CEO
Damo Consulting Inc

Bio info: Paddy Padmanabhan is an award-winning business leader and entrepreneur with deep experience in healthcare technology...

Paddy Padmanabhan is an award-winning business leader and entrepreneur with deep experience in healthcare technology markets. He is the author of the best-selling book Healthcare Digital Transformation - How Consumerism, technology and Pandemic are Accelerating the Future (Taylor and Francis, Aug 2020). Paddy has worked extensively as a technology strategist and trusted advisor to C-suite executives in large health systems and digital health firms. He is the Founder and CEO of Damo Consulting Inc., a digital transformation and growth advisory firm focused on the Healthcare sector.

Kash Patel

Vice President and Chief Digital Technology Officer
Penn Medicine

Bio info: Kash Patel is the vice president and chief digital technology officer at Penn Medicine. Kash has over 20 years’...

Kash Patel is the vice president and chief digital technology officer at Penn Medicine. Kash has over 20 years’ experience in technology leadership ranging from startups to multi-national corporations and is a seasoned leader in healthcare with a strong focus on innovation and building great teams.

At Penn Medicine, Kash is leading the world class Pearlman School of Medicine Information Technology team. He supports the areas of research, clinical trials, manufacturing high performance computing, informatics, genomic science and many others. In addition, Kash is responsible for all of bespoke software development. The team has been credited with several innovations that are streaming the complex business of healthcare. In 2020 there is a large focus on COVID-19 activities, working with Microsoft, Google and Apple to develop novel solutions that reflect Penn Medicine’s outstanding reputation.